These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

612 related items for PubMed ID: 8313427

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Potassium and calcium current blocking properties of the novel antiarrhythmic agent H 345/52: implications for proarrhythmic potential.
    Amos GJ, Abrahamsson C, Duker G, Hondeghem L, Palmer M, Carlsson L.
    Cardiovasc Res; 2001 Feb 01; 49(2):351-60. PubMed ID: 11164845
    [Abstract] [Full Text] [Related]

  • 3. Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit.
    Jacobson I, Carlsson L, Duker G.
    J Pharmacol Toxicol Methods; 2011 Feb 01; 63(1):40-6. PubMed ID: 20451633
    [Abstract] [Full Text] [Related]

  • 4. Proarrhythmic effects of intravenous quinidine, amiodarone, D-sotalol, and almokalant in the anesthetized rabbit model of torsade de pointes.
    Farkas A, Leprán I, Papp JG.
    J Cardiovasc Pharmacol; 2002 Feb 01; 39(2):287-97. PubMed ID: 11791015
    [Abstract] [Full Text] [Related]

  • 5. Female gender does not influence the magnitude of ibutilide-induced repolarization delay and incidence of torsades de pointes in an in vivo rabbit model of the acquired long QT syndrome.
    Johansson M, Carlsson L.
    J Cardiovasc Pharmacol Ther; 2001 Jul 01; 6(3):247-54. PubMed ID: 11584331
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Electrocardiographic and clinical predictors of torsades de pointes induced by almokalant infusion in patients with chronic atrial fibrillation or flutter: a prospective study.
    Houltz B, Darpö B, Edvardsson N, Blomström P, Brachmann J, Crijns HJ, Jensen SM, Svernhage E, Vallin H, Swedberg K.
    Pacing Clin Electrophysiol; 1998 May 01; 21(5):1044-57. PubMed ID: 9604236
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antiarrhythmic effects of potassium channel openers in rhythm abnormalities related to delayed repolarization.
    Carlsson L, Abrahamsson C, Drews L, Duker G.
    Circulation; 1992 Apr 01; 85(4):1491-500. PubMed ID: 1555289
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization.
    Hasumi H, Matsuda R, Shimamoto K, Hata Y, Kaneko N.
    Eur J Pharmacol; 2007 Jan 19; 555(1):54-60. PubMed ID: 17112502
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Rhythm anomalies related to delayed repolarization in vivo: influence of sarcolemmal Ca++ entry and intracellular Ca++ overload.
    Carlsson L, Drews L, Duker G.
    J Pharmacol Exp Ther; 1996 Oct 19; 279(1):231-9. PubMed ID: 8858998
    [Abstract] [Full Text] [Related]

  • 14. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.
    Hii JT, Wyse DG, Gillis AM, Duff HJ, Solylo MA, Mitchell LB.
    Circulation; 1992 Nov 19; 86(5):1376-82. PubMed ID: 1423949
    [Abstract] [Full Text] [Related]

  • 15. Lidocaine and nisoldipine attenuate almokalant-induced dispersion of repolarization and early afterdepolarizations in vitro.
    Abrahamsson C, Carlsson L, Duker G.
    J Cardiovasc Electrophysiol; 1996 Nov 19; 7(11):1074-81. PubMed ID: 8930739
    [Abstract] [Full Text] [Related]

  • 16. Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT prolongation.
    Eckardt L, Breithardt G, Haverkamp W.
    J Pharmacol Exp Ther; 2002 Jan 19; 300(1):64-71. PubMed ID: 11752098
    [Abstract] [Full Text] [Related]

  • 17. Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome.
    van Opstal JM, Schoenmakers M, Verduyn SC, de Groot SH, Leunissen JD, van Der Hulst FF, Molenschot MM, Wellens HJ, Vos MA.
    Circulation; 2001 Nov 27; 104(22):2722-7. PubMed ID: 11723026
    [Abstract] [Full Text] [Related]

  • 18. Attenuation of proarrhythmias related to delayed repolarization by low-dose lidocaine in the anesthetized rabbit.
    Carlsson L, Drews L, Duker G, Schiller-Linhardt G.
    J Pharmacol Exp Ther; 1993 Dec 27; 267(3):1076-80. PubMed ID: 8263767
    [Abstract] [Full Text] [Related]

  • 19. Effects of class III antiarrhythmic agents in an in vitro rabbit model of spontaneous torsades de pointe.
    D'Alonzo AJ, Zhu JL, Darbenzio RB.
    Eur J Pharmacol; 1999 Mar 12; 369(1):57-64. PubMed ID: 10204682
    [Abstract] [Full Text] [Related]

  • 20. Azimilide and dofetilide produce similar electrophysiological and proarrhythmic effects in a canine model of Torsade de Pointes arrhythmias.
    Van Opstal JM, Leunissen JD, Wellens HJ, Vos MA.
    Eur J Pharmacol; 2001 Jan 19; 412(1):67-76. PubMed ID: 11166738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.